You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PDAC

Showing 1 - 25 of 350
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

"Effect of Screening Using Imaging on Early Detection of PDAC in

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • A blood sample for CA 19-9 (cancer detection test)
  • (no location specified)
Sep 13, 2023

Pancreatic Ductal Adenocarcinoma Trial in Toronto (Durvalumab, Oleclumab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 22, 2023

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Bio-specimen Collection: Blood
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 21, 2023

PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)

Not yet recruiting
  • PDAC - Pancreatic Ductal Adenocarcinoma
  • Combination of sitagliptin+ gemcitabine + nab-paclitaxel
  • (no location specified)
Jul 9, 2023

Pancreas Cancer, Exosomes, Extracellular Vesicles Trial

Not yet recruiting
  • Pancreas Cancer
  • +3 more
    • (no location specified)
    Dec 6, 2022

    Pancreas Cancer Trial in San Francisco (Educational Materials for a new diagnostic test)

    Not yet recruiting
    • Pancreas Cancer
    • Educational Materials for a new diagnostic test
    • San Francisco, California
      QURE Healthcare
    Jan 26, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • +12 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 30, 2022

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Indianapolis (Lonsurf, Gemcitabine, Nab-Paclitaxel)

    Active, not recruiting
    • Pancreatic Cancer
    • Pancreatic Ductal Adenocarcinoma
    • Indianapolis, Indiana
      Indiana University Melvin & Bren Simon Cancer Center
    Nov 29, 2022

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Boston (other, diagnostic test, combination product)

    Not yet recruiting
    • Pancreatic Cancer
    • +4 more
    • Screening Blood Tests
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Nov 3, 2023

    PDAC - Pancreatic Ductal Adenocarcinoma Trial in Verona (Register)

    Recruiting
    • PDAC - Pancreatic Ductal Adenocarcinoma
    • Register
    • Verona, Italy
      AOUI Verona
    May 3, 2023

    Precise Gene Signature for Predicting Outcomes in PDAC

    Completed
    • Stage I-II Pancreatic Ductal Adenocarcinoma (PDAC)
    • Precise Prognostic and Predictive Signature
    • Resection
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Jul 1, 2022

    PDAC - Pancreatic Ductal Adenocarcinoma Trial in Verona (ctDNA analysis)

    Recruiting
    • PDAC - Pancreatic Ductal Adenocarcinoma
    • ctDNA analysis
    • Verona, Italy
      AOUI Verona
    May 8, 2023

    Microbiota and Metabolites Alterations in Pancreatic Head and

    Completed
    • Pancreatic Ductal Adenocarcinoma (PDAC)
    • 16S rRNA amplicon sequencing and untargeted metabolomics
    • Jinan, Shandong, China
      Qilu Hospital of Shandong University
    Nov 27, 2023

    Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
      • Liverpool, United Kingdom
      • +3 more
      Aug 10, 2022

      Pancreatic Ductal Adenocarcinoma Trial in Saint Louis (BMS-813160, Nivolumab, Gemcitabine)

      Active, not recruiting
      Has Results
      • Pancreatic Ductal Adenocarcinoma
      • Saint Louis, Missouri
        Washington University School of Medicine
      Dec 8, 2022

      Pancreatic Cancer Trial in New York (Chemotherapy, Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA))

      Not yet recruiting
      • Pancreatic Cancer
      • Chemotherapy
      • Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA)
      • New York, New York
        Tisch Hospital
      Feb 9, 2023

      PDAC, Pancreatoduodenectomy, Margin, Resection Trial in Duesseldorf (oncological relevance of the mesopancreas)

      Not yet recruiting
      • PDAC
      • +4 more
      • oncological relevance of the mesopancreas
      • Duesseldorf, Germany
        University Hospital Duesseldorf, Heinrich Heine University
      May 30, 2023

      Pancreatic Cancer, Surgery Trial in København, Køge (Propranolol, Placebo)

      Not yet recruiting
      • Pancreatic Cancer
      • Surgery
      • København, Denmark
      • +1 more
      Nov 17, 2023

      PDAC - Pancreatic Ductal Adenocarcinoma Trial in Nijmegen (CT Perfusion)

      Recruiting
      • PDAC - Pancreatic Ductal Adenocarcinoma
      • CT Perfusion
      • Nijmegen, Gelderland, Netherlands
        Radboud University Medical Hospital
      Dec 20, 2022

      PDAC - Pancreatic Ductal Adenocarcinoma Trial in Los Angeles (6D-MRI)

      Recruiting
      • PDAC - Pancreatic Ductal Adenocarcinoma
      • 6D-MRI
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Oct 5, 2021

      Metastatic Pancreatic Ductal Adenocarcinoma Trial in Belgium (Nanoliposomal irinotecan, 5 FU, Leucovorin)

      Recruiting
      • Metastatic Pancreatic Ductal Adenocarcinoma
      • Nanoliposomal irinotecan
      • +3 more
      • Brugge, West-Vlaanderen, Belgium
      • +11 more
      Jul 25, 2022

      Pancreatic Cancer Recurrence in the Netherlands

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • +3 more
        • Utrecht, Netherlands
          UMC Utrecht
        Feb 1, 2023

        Follow-up of High-risk Population of PDAC Based on EUS

        Not yet recruiting
        • Carcinoma, Pancreatic Ductal
        • Endoscopic ultrasound
        • EUS-Fine needle aspiration
        • (no location specified)
        Nov 18, 2022

        Pancreatic Cancer, Pancreatic Adenocarcinoma, Pancreas Ductal Adenocarcinoma Trial in United States (Nab-paclitaxel and

        Active, not recruiting
        • Pancreatic Cancer
        • +2 more
        • Nab-paclitaxel and gemcitabine for R-PDAC Patients
        • Nab-paclitaxel and gemcitabine for BR-PDAC Patients
        • Scottsdale, Arizona
        • +3 more
        Mar 8, 2022

        Metastatic Pancreatic Cancer Trial in Spain (OMO-103, Nab-Paclitaxel, Gemcitabine)

        Recruiting
        • Metastatic Pancreatic Cancer
        • L´Hospitalet de Llobregat, Barcelona, Spain
        • +3 more
        Sep 22, 2023